Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

JNJ PFE NVS SNY Investor Favorites Apparel Data Storage Cars 
Benchmark SP 500  1,629   22.88  Index Moved Down -1.39% United States ...


Processing
Processing. Please wait...

BristolMyers Total Debt

 
 Companies |  Insiders  | Dashboard  
     
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principle payments will eventually prevent the firm from borrow excessively.

BristolMyers

Total Debt

=

Bonds

+

Notes

=
7.89 B
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
Compare BristolMyers to competition

BristolMyers Total Debt Assessment

Based on latest financial disclosure BristolMyers Squibb Company has Total Debt of 7.89 B. This is 437.31% higher than that of Healthcare sector, and 30.11% higher than that of Drug Manufacturers - Major industry, The Total Debt for all stocks is 49.18% lower than the firm.

Filter other Stocks by Total Debt

Specify Market Cap
Select Total Debt Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  
Follow BristolMyers Total Debt with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add BristolMyers to your reader
 
    
BMY United States NYSE
BristolMyers Squibb Company
Benchmark S&P 500
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
    

Other BristolMyers Fundamentals

Return On Equity10.97 %
Return On Asset6.39 %
Profit Margin9.06 %
Operating Margin21.57 %
Current Valuation80.93 B
Shares Outstanding1.64 B
Shares Owned by Insiders0.15 %
Shares Owned by Institutions67.60 %
Number of Shares Shorted29.52 M
Price to Earning53.90 times
Price to Book5.53 times
Price to Sales4.66 times
Revenue16.2 B
Gross Profit13.01 B
EBITDA4.62 B
Net Income1.47 B
Cash and Equivalents2.53 B
Cash per Share1.54 times
Total Debt7.89 B
Debt to Equity0.58 times
Current Ratio1.20 times
Book Value Per Share8.32 times
Cash Flow from Operations6.13 B
Short Ratio3.20 times
One Year High49.57
One Year Low30.64
Earnings Per Share0.88 times
Price to Earnings To Growth2.68 times
Number of Employees28 K
Beta0.01
Market Capitalization78.17 B
Total Asset35.96 B
Retained Earnings32.76 B
Working Capital1.66 B
Current Asset10.08 B
Current Liabilities8.41 B
Z Score5.4
Probability Of Bankruptcy12.50 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium